dc.creatorGrinberg, Lea Tenenholz
dc.creatorKorczyn, Amos D.
dc.creatorHeinsen, Helmut
dc.date.accessioned2013-10-29T13:05:17Z
dc.date.accessioned2018-07-04T16:06:51Z
dc.date.available2013-10-29T13:05:17Z
dc.date.available2018-07-04T16:06:51Z
dc.date.created2013-10-29T13:05:17Z
dc.date.issued2012
dc.identifierEXPERIMENTAL GERONTOLOGY, OXFORD, v. 47, n. 11, supl. 1, Part 3, pp. 838-842, NOV, 2012
dc.identifier0531-5565
dc.identifierhttp://www.producao.usp.br/handle/BDPI/36298
dc.identifier10.1016/j.exger.2012.08.005
dc.identifierhttp://dx.doi.org/10.1016/j.exger.2012.08.005
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1631597
dc.description.abstractCerebral amyloid angiopathy (CAA) is an age-associated disease characterized by amyloid deposition in cerebral and meningeal vessel walls. CAA is detected in the majority of the individuals with dementia and also in a large number of non-demented elderly individuals. In addition, CAA is strongly associated with Alzheimer's disease (AD) pathology. Mechanical consequences including intra-cerebral or subarachnoid hemorrhage remains CAA most feared complication, but only a small fraction of CAA results in severe bleeding. On the hand the non-mechanical consequences in cerebrovascular regulation are prevalent and may be even more deleterious. Studies of animal models have provided strong evidence linking the vasoactive A beta 1-40, the main species found in CAA, to disturbances in endothelial-dependent factors, disrupting cerebrovascular regulation Here, we aimed to review experimental findings regarding the non-mechanical consequences of CAA for cerebrovascular regulation and discuss the implications of these results to clinical practice. (C) 2012 Elsevier Inc. All rights reserved.
dc.languageeng
dc.publisherPERGAMON-ELSEVIER SCIENCE LTD
dc.publisherOXFORD
dc.relationEXPERIMENTAL GERONTOLOGY
dc.rightsCopyright PERGAMON-ELSEVIER SCIENCE LTD
dc.rightsclosedAccess
dc.subjectAMYLOID
dc.subjectANGIOPATHY
dc.subjectDEMENTIA
dc.subjectALZHEIMER'S DISEASE
dc.subjectANIMAL MODELS
dc.subjectENDOTHELIUM
dc.subjectCEREBROVASCULAR DYSFUNCTION
dc.subjectBLOOD BRAIN BARRIER
dc.titleCerebral amyloid angiopathy impact on endothelium
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución